Phase I/II study of a chemotherapy combination consisting of pemetrexed and cisplatin with concomitant radiotherapy, followed by consolidation chemotherapy with pemetrexed in patients with locally advanced inoperable NSCLC.

Trial Profile

Phase I/II study of a chemotherapy combination consisting of pemetrexed and cisplatin with concomitant radiotherapy, followed by consolidation chemotherapy with pemetrexed in patients with locally advanced inoperable NSCLC.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2011

At a glance

  • Drugs Cisplatin; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Lilly Espana
  • Most Recent Events

    • 08 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top